2/20/2024 | BK | Moody’s moves ANI outlook to positive
|
10/19/2023 | BK | S&P revises ANI outlook to positive
|
8/29/2022 | BK | S&P turns ANI outlook to stable
|
5/24/2021 | BK | Market Commentary: Rocket, ANI, Digital Media, break; American Rock tweaked; MetroNet, West Marine accelerated
|
5/24/2021 | CLHY | Market Commentary: Rocket, ANI, Digital Media, break; American Rock tweaked; MetroNet, West Marine accelerated
|
5/19/2021 | BK | ANI raises spread on $300 million term loan to Libor plus 600 bps
|
4/29/2021 | BK | Market Commentary: United Pacific, Ahead DB, Insulet, Mitratech break; PQ, Cubic, Alliant updates surface
|
4/29/2021 | CLHY | Market Commentary: United Pacific, Ahead DB, Insulet, Mitratech break; PQ, Cubic, Alliant updates surface
|
4/29/2021 | BK | ANI launches $300 million term loan at Libor plus 525-550 bps
|
4/27/2021 | BK | Market Commentary: Birkenstock breaks; Insulet, Press Ganey, Surgery Partners tweak deals; PQ moves deadline
|
4/27/2021 | CLHY | Market Commentary: Birkenstock breaks; Insulet, Press Ganey, Surgery Partners tweak deals; PQ moves deadline
|
4/27/2021 | BK | Moody's assigns ANI B2
|
4/27/2021 | BK | S&P rates ANI B+
|
4/27/2021 | BK | ANI readies launch of $340 million credit facilities for Thursday
|
3/9/2021 | BK | ANI plans $340 million credit facilities with Novitium purchase
|
12/2/2019 | BK | ANI Pharmaceuticals uses delayed-draw term loan to repay convertibles
|
12/27/2018 | BK | ANI Pharmaceuticals adds $118 million delayed-draw loan, ups revolver
|
1/5/2018 | BK | ANI Pharmaceuticals gets $125 million five-year senior credit facility
|
12/29/2017 | BK | ANI Pharmaceuticals obtains five-year $125 million credit facility
|
4/14/2015 | PP | ANI Pharmaceuticals has $169 million available for M&A activities
|
4/14/2015 | BWCV | ANI Pharmaceuticals has $169 million available for M&A activities
|
12/10/2014 | CV | ANI Pharmaceuticals greenshoe ups convertible sale to $143.75 million
|
12/5/2014 | PP | Market Commentary: New PROS, new ANI edge up; Cyan prices; Cobalt trades lower; Fiat Chrysler deal eyed
|
12/5/2014 | CV | Market Commentary: New PROS, new ANI edge up; Cyan prices; Cobalt trades lower; Fiat Chrysler deal eyed
|
12/5/2014 | CV | Market Commentary: Morning Commentary: New PROS adds; new ANI up slightly; energy sector names steady
|
12/5/2014 | CV | New Issue: ANI Pharmaceuticals prices upsized $125 million five-year convertibles at 3%, up 30%
|
12/4/2014 | PP | Market Commentary: NXP Semiconductors extends gains; energy sector heavy; ANI Pharmaceuticals on tap
|
12/4/2014 | CV | Market Commentary: NXP Semiconductors extends gains; energy sector heavy; ANI Pharmaceuticals on tap
|
12/4/2014 | CV | Market Commentary: Morning Commentary: NXP Semiconductors extends gains; PROS, ANI Pharmaceuticals on tap
|
12/4/2014 | CV | ANI Pharmaceuticals to price $100 million five-year convertibles to yield 3%-3.5%, up 25%-30%
|
3/10/2014 | PP | ANI greenshoe exercised for $50 million public sale of common stock
|
3/5/2014 | PP | ANI Pharmaceuticals prices $43.48 million public stock sale at $31.00
|
3/4/2014 | PP | ANI Pharmaceuticals intends to price public offering of common stock
|